At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura, a ...

Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel ...

Five AI-based technologies that can be used during a colonoscopy exam to help detect the early signs of bowel cancer have ...

A mental health campaigner has condemned the "stunning silence" from mainstream media in the UK after the first-ever men's ...

Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease ...

Whilst there, pharmaphorum editor-in-chief Jonah Comstock and web editor Nicole Raleigh, together with Frontiers Health ...

At Frontiers Health 2025, we capturedoff-stage conversations with Renzo DiCarlo (AstraZeneca) and James Kugler (EMD Digital), ...

The commercialisation landscape in pharma is undergoing rapid transformation. At Frontiers Health 2025, we took the ...

The FDA has given accelerated approval to Bayer for oral HER2 tyrosine kinase inhibitor sevabertinib as a second-line treatment for advanced HER2-mutant non-small cell lung cancer (NSCLC), allowing it ...

Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...

Bayer has billed Lynkuet as its next major pharma launch, saying it is due to start rolling out in the US later this month, ...